National Vision Holdings Inc. (EYE) Insider Trading

Last 12 months

Insiders bought $776k and sold $1.27M on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

−$498k

1 buy · 2 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

1 / 2

executives and directors

Last open-market buy

Jun 2026

Jun 5, 2026

Get an email when EYE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 5	Michael J Nicholson Director	Bought	50,000	$15.52	$776k	466%	Form 4
Mar 11	Alexander Wilkes Chief Executive Officer	Sold10b5-1 plan	35,000	$26.54	$929k	68%	Form 4
Mar 6	L Reade Fahs Executive Chairman	Sold10b5-1 plan 2 parts	11,672	$29.58 average	$345k	1.1%	Form 4
Sep 15, 2025 – Sep 16, 2025	L Reade Fahs Executive Chairman	Sold10b5-1 plan 2 parts	12,600	$23.91 average	$301k	1.4%	Form 4
Aug 28, 2025	L Reade Fahs Executive Chairman	Sold10b5-1 plan 2 parts	137,400	$24.33 average	$3.34M	13%	Form 4
May 14, 2025	Megan Molony SVP, CHIEF MERCH. & MC OFFICER	SoldNo plan	3,900	$18.90	$74k	41%	Form 4
May 13, 2025	Ravi Acharya SVP, Chief Technology Officer	SoldNo plan	12,000	$18.76	$225k	51%	Form 4
Mar 1, 2025	Joseph Vandette SVP, Chief Marketing Officer	SoldNo plan	1,179	$12.71	$15k	7.4%	Form 4

Jun 5
Michael J Nicholson
Director · bought 50,000 at $15.52
$776k
466% of stake
Mar 1110b5-1 plan
Alexander Wilkes
Chief Executive Officer · sold 35,000 at $26.54
$929k
68% of stake
Mar 610b5-1 plan
L Reade Fahs
Executive Chairman · sold 11,672 at avg $29.58
$345k
1.1% of stake
Sep 15, 2025 – Sep 16, 202510b5-1 plan
L Reade Fahs
Executive Chairman · sold 12,600 at avg $23.91
$301k
1.4% of stake
Aug 28, 202510b5-1 plan
L Reade Fahs
Executive Chairman · sold 137,400 at avg $24.33
$3.34M
13% of stake
May 14, 2025No plan
Megan Molony
SVP, CHIEF MERCH. & MC OFFICER · sold 3,900 at $18.90
$74k
41% of stake
May 13, 2025No plan
Ravi Acharya
SVP, Chief Technology Officer · sold 12,000 at $18.76
$225k
51% of stake
Mar 1, 2025No plan
Joseph Vandette
SVP, Chief Marketing Officer · sold 1,179 at $12.71
$15k
7.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch EYE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Ophthalmic Goods

WRBYWarby Parker Inc.

STAAStaar Surgical Company

COOThe Cooper Companies, Inc.

BLCOBausch + Lomb Corporation

MSAMsa Safety Inc.

ICUIIcu Medical Inc.

RALRalliant Corporation

ITGRInteger Holdings Corporation

Spot a number that looks wrong? Check it in EYE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EYE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.